Last10K.com

Avid Bioservices, Inc. (CDMO) SEC Filing 8-K Material Event for the period ending Thursday, December 3, 2020

Avid Bioservices, Inc.

HISTORY TOOLS
CIK: 704562 Ticker: CDMO

View differences made from one to another to evaluate Avid Bioservices, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Avid Bioservices, Inc..

Continue

Assess how Avid Bioservices, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Avid Bioservices, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Avid Bioservices, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Press Release
Ticker: CDMO
CIK: 704562
Form Type: 8-K Corporate News
Accession Number: 0001683168-20-004189
Submitted to the SEC: Mon Dec 07 2020 4:37:14 PM EST
Accepted by the SEC: Mon Dec 07 2020
Period: Thursday, December 3, 2020
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/cdmo/0001683168-20-004189.htm